LGND
LIGAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$297.28
+0.59%Forward multiples
Based on analyst estimates
- P/E forward
- 26.93x
- P/E 2026E
- 32.11x
- P/E 2027E
- 24.67x
- P/E 2028E
- 20.49x
- P/S forward
- 16.94x
Trailing multiples
Trailing twelve months
- P/E TTM
- 29.70x
- PEG TTM
- 2.90x
- Price / book
- 6.13x
- Price / sales
- 20.40x
- Price / cash flow
- 45.02x
Enterprise value
- Enterprise value
- $5.7B
- EV / sales
- 19.62x
- EV / EBITDA
- 20.80x
- EV / EBIT
- 56.48x
- Market cap
- $5.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026